The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse

Bryan Yamamoto, Jamie Raudensky

Research output: Contribution to journalReview article

92 Citations (Scopus)

Abstract

Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are amphetamine derivatives with high abuse liability. These amphetamine-related drugs of abuse mediate their effects through the acute activation of both dopaminergic and serotonergic neurons. Long-term abuse of these amphetamine derivatives, however, results in damage to both dopaminergic and serotonergic terminals throughout the brain. This toxicity is mediated in part by oxidative stress, metabolic compromise, and inflammation. The overall objective of this review is to highlight experimental evidence that METH and MDMA increase oxidative stress, produce mitochondrial dysfunction, and increase inflammation that converge and culminate in the long-term toxicity to dopaminergic and serotonergic neurons.

Original languageEnglish (US)
Pages (from-to)203-217
Number of pages15
JournalJournal of NeuroImmune Pharmacology
Volume3
Issue number4
DOIs
StatePublished - Dec 2008
Externally publishedYes

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Street Drugs
Amphetamine
Serotonergic Neurons
Oxidative Stress
Methamphetamine
Dopaminergic Neurons
Inflammation
Wounds and Injuries
Amphetamine-Related Disorders
Brain

Keywords

  • Inflammation
  • Matrix metalloproteinase
  • MDMA
  • Methamphetamine
  • Mitochondrial dysfunction
  • Oxidative stress

ASJC Scopus subject areas

  • Pharmacology
  • Immunology and Allergy
  • Immunology
  • Neuroscience (miscellaneous)

Cite this

@article{0d3381309acf4403acec6010aac291a3,
title = "The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse",
abstract = "Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are amphetamine derivatives with high abuse liability. These amphetamine-related drugs of abuse mediate their effects through the acute activation of both dopaminergic and serotonergic neurons. Long-term abuse of these amphetamine derivatives, however, results in damage to both dopaminergic and serotonergic terminals throughout the brain. This toxicity is mediated in part by oxidative stress, metabolic compromise, and inflammation. The overall objective of this review is to highlight experimental evidence that METH and MDMA increase oxidative stress, produce mitochondrial dysfunction, and increase inflammation that converge and culminate in the long-term toxicity to dopaminergic and serotonergic neurons.",
keywords = "Inflammation, Matrix metalloproteinase, MDMA, Methamphetamine, Mitochondrial dysfunction, Oxidative stress",
author = "Bryan Yamamoto and Jamie Raudensky",
year = "2008",
month = "12",
doi = "10.1007/s11481-008-9121-7",
language = "English (US)",
volume = "3",
pages = "203--217",
journal = "Journal of NeuroImmune Pharmacology",
issn = "1557-1890",
publisher = "Springer New York",
number = "4",

}

TY - JOUR

T1 - The role of oxidative stress, metabolic compromise, and inflammation in neuronal injury produced by amphetamine-related drugs of abuse

AU - Yamamoto, Bryan

AU - Raudensky, Jamie

PY - 2008/12

Y1 - 2008/12

N2 - Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are amphetamine derivatives with high abuse liability. These amphetamine-related drugs of abuse mediate their effects through the acute activation of both dopaminergic and serotonergic neurons. Long-term abuse of these amphetamine derivatives, however, results in damage to both dopaminergic and serotonergic terminals throughout the brain. This toxicity is mediated in part by oxidative stress, metabolic compromise, and inflammation. The overall objective of this review is to highlight experimental evidence that METH and MDMA increase oxidative stress, produce mitochondrial dysfunction, and increase inflammation that converge and culminate in the long-term toxicity to dopaminergic and serotonergic neurons.

AB - Methamphetamine (METH) and 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) are amphetamine derivatives with high abuse liability. These amphetamine-related drugs of abuse mediate their effects through the acute activation of both dopaminergic and serotonergic neurons. Long-term abuse of these amphetamine derivatives, however, results in damage to both dopaminergic and serotonergic terminals throughout the brain. This toxicity is mediated in part by oxidative stress, metabolic compromise, and inflammation. The overall objective of this review is to highlight experimental evidence that METH and MDMA increase oxidative stress, produce mitochondrial dysfunction, and increase inflammation that converge and culminate in the long-term toxicity to dopaminergic and serotonergic neurons.

KW - Inflammation

KW - Matrix metalloproteinase

KW - MDMA

KW - Methamphetamine

KW - Mitochondrial dysfunction

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=55849102476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55849102476&partnerID=8YFLogxK

U2 - 10.1007/s11481-008-9121-7

DO - 10.1007/s11481-008-9121-7

M3 - Review article

VL - 3

SP - 203

EP - 217

JO - Journal of NeuroImmune Pharmacology

JF - Journal of NeuroImmune Pharmacology

SN - 1557-1890

IS - 4

ER -